Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001967722-25-000002
Filing Date
2025-06-30
Accepted
2025-06-30 17:59:03
Documents
1
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1751320735.html 4  
1 FORM 4 wk-form4_1751320735.xml 4 3829
  Complete submission text file 0001967722-25-000002.txt   5302
Mailing Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203
Business Address 2100 WHARTON STREET SUITE 701 PITTSBURGH PA 15203 (412) 586-5830
Krystal Biotech, Inc. (Issuer) CIK: 0001711279 (see all company filings)

EIN.: 821080209 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O KRYSTAL BIOTECH, INC. 2100 WHARTON STREET, SUITE 701 PITTSBURGH PA 15203
Business Address
Mazzacco Catherine (Reporting) CIK: 0001967722 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38210 | Film No.: 251093535